BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 26, 2008
View Archived Issues
Improved in vitro profile and therapeutic index with Pfizer's new bronchodilator UK-503590
Read More
Targeting the GPR4 receptor shows benefit in models of lung injury and COPD
Read More
Johnson & Johnson new LTA4H inhibitor reduces allergic airways inflammation in vivo
Read More
ST-2472 exhbits potent antipsychotic effects and good safety profile in vivo
Read More
Antitumor effects of chemotherapy enhanced by inhibition of N-cadherin
Read More
Novel mechanism for benzodiazepine receptor ligand PK-11195 identified
Read More
Medivir reports new therapeutic options for HCV infection in recent patent
Read More
Recent patents describe novel treatment alternatives for eye disorders
Read More
Recent patents disclose novel anti-HIV agents
Read More
Recent patents impart novel treatment options for cancer
Read More
DOR BioPharma withdraws E.U. MAA for orBec and plans phase III study
Read More
Allon completes dosing in phase II AL-208 cognitive impairment trial
Read More
FDA issues approvable letter for bazedoxifene in postmenopausal osteoporosis
Read More
GTx phase III toremifene trial continues after interim efficacy analysis
Read More
Novo Nordisk files for regulatory approval of liraglutide in the U.S. and Europe
Read More
ProStrakan grants exclusive license to JapanBridge for Sancuso in parts of Asia
Read More
Panobinostat active against poorly differentiated and anaplastic thyroid carcinoma cells
Read More
First patients enrolled in switch trial of oral iclaprim
Read More
Synthetic Blood International obtains exclusive license to VCU discoveries
Read More
Draxis Health acquisition approved by shareholders
Read More
First MS therapeutic from Novartis approved for launch in Europe
Read More